Gaingels is a globally distributed investment syndicate founded in the mid-2010s that operates through a large network of accredited investors. It co-invests across venture rounds, typically alongside leading institutional firms, and has become one of the largest diversity-focused investor networks globally.

Its investment model is centered on backing companies with diverse leadership, particularly LGBTQ+ representation, and on actively improving diversity at the board and executive level. Beyond capital, Gaingels provides access to a broad investor and operator network, as well as support in talent, governance, and board composition, making it a strategic partner for companies looking to strengthen inclusion at scale.

Rather than being sector-specific, Gaingels applies this diversity-led thesis across a wide range of industries, including health and deep tech. For neurotechnology companies, it is best understood as a co-investor rather than a domain specialist, particularly valuable in rounds where access to capital networks, rapid syndication, and diversity alignment are important factors.